Publications by authors named "Helena Harlin"

Claim this Profile
P
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.
C Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, Helena Harlin, Dimitrios Mougiakakos

Cancer Immunol Immunother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.
Helena Harlin, Yuru Meng, Amy C Peterson, Yuanyuan Zha, Maria Tretiakova

Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of immunomodulating genes in prostate cancer and benign prostatic tissue.
Anca Reschner, Helena Harlin, Brett Laven, Fredrik Eriksson, Pavel Pisa

Anal Quant Cytol Histol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.
David Knight, Amy C Peterson, Brian I Rini, Helena Harlin, Thomas F Gajewski

Prostate· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of mycoplasma-contaminated cell cultures.
Helena Harlin, Thomas F Gajewski

Curr Protoc Cytom· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.
Helena Harlin, Mikael Hanson, C Christian Johansson, Daiju Sakurai, Isabel Poschke

J Immunol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.
Helena Harlin, Todd V Kuna, Amy C Peterson, Yuru Meng, Thomas F Gajewski

Cancer Immunol Immunother· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune resistance orchestrated by the tumor microenvironment.
Thomas F Gajewski, Yuru Meng, Christian Blank, Ian Brown, Aalok Kacha, Helena Harlin

Immunol Rev· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression.
Yuru Meng, Helena Harlin, James P O'Keefe, Thomas F Gajewski

J Immunol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune suppression in the tumor microenvironment.
Thomas F Gajewski, Yuru Meng, Helena Harlin

J Immunother· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Amy C Peterson, Helena Harlin, Theodore Karrison, Nicholas J Vogelzang, James A Knost

Invest New Drugs· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of Mycoplasma-contaminated cell cultures.
Helena Harlin, Thomas F Gajewski

Curr Protoc Microbiol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.
Todd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, Seth Berk, Evie Sprague

J Clin Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines.
Katharina Tschoep, Thomas C Manning, Helena Harlin, Christopher George, Melissa Johnson

J Leukoc Biol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.
Amy C Peterson, Helena Harlin, Thomas F Gajewski

J Clin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism.
Helena Harlin, Eckhard Podack, Mark Boothby, Maria-Luisa Alegre

J Immunol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA-4 engagement regulates NF-kappaB activation in vivo.
Helena Harlin, Kwang Woo Hwang, David A Palucki, Oliver Kim, Craig B Thompson

Eur J Immunol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis